{"id":11389,"date":"2021-08-04T09:00:06","date_gmt":"2021-08-04T14:00:06","guid":{"rendered":"https:\/\/backup.primeaction.com\/sp\/?p=11389"},"modified":"2021-07-28T10:35:38","modified_gmt":"2021-07-28T15:35:38","slug":"bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico","status":"publish","type":"post","link":"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/","title":{"rendered":"Bayer Pharma crece a doble d\u00edgito y gana mercado en M\u00e9xico"},"content":{"rendered":"

Aun dentro del entorno dif\u00edcil para la industria farmac\u00e9utica en M\u00e9xico por la restricci\u00f3n presupuestal y el cambio radical en las compras de gobierno, a las trasnacionales de medicamentos innovadores les ha ayudado la estabilidad del tipo de cambio peso-d\u00f3lar, ya que sus productos son importados y esto les ha permitido seguirse expandiendo, sobre todo en el sector privado.<\/p>\n

As\u00ed lo expone Jorge Ancona, director general de Bayer Pharma en M\u00e9xico, y explica que a diferencia de otros pa\u00edses de Am\u00e9rica Latina, el mercado mexicano est\u00e1 teniendo un alto dinamismo, aparte de la paridad cambiaria, por otras varias razones: la migraci\u00f3n del gasto en salud hacia el sector privado, la demanda por Covid sobre todo a inicios del 2021, la mayor conciencia de la gente por cuidar su salud y un mayor apego al tratamiento de parte de pacientes con enfermedades cr\u00f3nico degenerativas.<\/p>\n

A este ritmo se estar\u00eda achicando la brecha que coloca a Brasil como n\u00famero uno y M\u00e9xico n\u00famero dos en la regi\u00f3n, al menos del lugar que ocupa el pa\u00eds dentro de Bayer.<\/p>\n

A sus casi 100 a\u00f1os en M\u00e9xico, Bayer crece a ritmo de doble d\u00edgito, al grado de que en cuesti\u00f3n de dos a\u00f1os logr\u00f3 escalar cuatro pelda\u00f1os en su posici\u00f3n en el ranking farmac\u00e9utico nacional pasando del lugar 10 al sexto de 2018 a la fecha.<\/p>\n

En el primer trimestre del 2021 elev\u00f3 sus ventas en 17%, por encima del mercado farma en general que creci\u00f3 un 12% en segmento privado y de 1 a 3% en sector p\u00fablico.<\/p>\n

En entrevista con El Economista, el directivo de la compa\u00f1\u00eda alemana explica que el reacomodo por la compra de Monsanto dej\u00f3 a la compa\u00f1\u00eda sentada en tres pilares: la de Crop Sciences de tecnolog\u00eda agr\u00edcola que representa 50% de ingresos, la de farma que \u00e9l dirige, con 27%, y la de Consumo con el restante 23% del negocio (donde qued\u00f3 por ejemplo la emblem\u00e1tica Aspirina).<\/p>\n

Ancona subraya que la decisi\u00f3n estrat\u00e9gica de apostarle a la innovaci\u00f3n interna y externa y a enriquecer el portafolio ya se refleja en seis lanzamientos para los pr\u00f3ximos tres a\u00f1os: dos para cardio, dos para oncolog\u00eda y dos para hemofilia. Para ello adquirieron una empresa de terapia celular y de gen\u00e9tica y hacia adelante se enfocar\u00e1n mucho en medicina personalizada.<\/p>\n

\u201cEn los pr\u00f3ximos 7-8 a\u00f1os Bayer estar\u00e1 enfocada en lanzamientos importantes que de verdad hagan la diferencia en \u00e1reas donde hay necesidades m\u00e9dicas no cubiertas\u201d, apunt\u00f3 al advertir que ya pas\u00f3 la etapa de la innovaci\u00f3n farmac\u00e9utica donde un nuevo producto es apenas marginalmente superior al anterior. \u201cEn medio de enormes retos de acceso, donde todos los pa\u00edses buscan c\u00f3mo gastar mejor en salud, ser\u00e1 muy dif\u00edcil que dichos productos tengan tracci\u00f3n\u201d.<\/p>\n

En el escenario mexicano, el capit\u00e1n de Bayer Pharma expresa su preocupaci\u00f3n sobre c\u00f3mo vengan las cosas tras la reforma fiscal que se discute porque el riesgo es que se quiera reducir a\u00fan m\u00e1s el de por s\u00ed limitado presupuesto en salud en un entorno donde hay una barrera de entendimiento sobre el costo\/beneficio que ofrecen las opciones de innovaci\u00f3n a mayor precio pero que en el mediano plazo generan ahorros y \u00f3ptimas eficiencias en la atenci\u00f3n.<\/p>\n

\u201cVisualizamos un entorno donde podemos seguir ofreciendo opciones innovadoras trabajando con UNOPS o con Insabi y con la parte m\u00e9dica o la de finanzas para lograr esquemas convenientes para la salud p\u00fablica del pa\u00eds, pero esto se enfrenta a una realidad presupuestal y entonces todo est\u00e1 por verse\u201d, comenta.<\/p>\n","protected":false},"excerpt":{"rendered":"

En dos a\u00f1os la empresa subi\u00f3 del pelda\u00f1o d\u00e9cimo al sexto en ventas a pesar del giro en compras p\u00fablicas de medicamentos, afirma su Jorge Ancona, su director en M\u00e9xico.<\/p>\n","protected":false},"author":10,"featured_media":11392,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"single-post.php","format":"standard","meta":{"_eb_attr":"","site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_mbp_gutenberg_autopost":false,"fifu_image_url":"https:\/\/www.eleconomista.com.mx\/__export\/1561682579285\/sites\/eleconomista\/img\/2019\/06\/27\/bayer.jpg_1093282975.jpg","fifu_image_alt":"Bayer Pharma crece a doble d\u00edgito y gana mercado en M\u00e9xico","footnotes":""},"categories":[6],"tags":[],"class_list":["post-11389","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-post-agronegocios"],"yoast_head":"\nBayer Pharma crece a doble d\u00edgito y gana mercado en M\u00e9xico · Prime Action Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bayer Pharma crece a doble d\u00edgito y gana mercado en M\u00e9xico · Prime Action Consulting\" \/>\n<meta property=\"og:description\" content=\"En dos a\u00f1os la empresa subi\u00f3 del pelda\u00f1o d\u00e9cimo al sexto en ventas a pesar del giro en compras p\u00fablicas de medicamentos, afirma su Jorge Ancona, su director en M\u00e9xico.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/\" \/>\n<meta property=\"og:site_name\" content=\"Prime Action Consulting\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-04T14:00:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.eleconomista.com.mx\/__export\/1561682579285\/sites\/eleconomista\/img\/2019\/06\/27\/bayer.jpg_1093282975.jpg\" \/>\n<meta name=\"author\" content=\"primeactionmx\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.eleconomista.com.mx\/__export\/1561682579285\/sites\/eleconomista\/img\/2019\/06\/27\/bayer.jpg_1093282975.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"primeactionmx\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bayer Pharma crece a doble d\u00edgito y gana mercado en M\u00e9xico · Prime Action Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/","og_locale":"es_ES","og_type":"article","og_title":"Bayer Pharma crece a doble d\u00edgito y gana mercado en M\u00e9xico · Prime Action Consulting","og_description":"En dos a\u00f1os la empresa subi\u00f3 del pelda\u00f1o d\u00e9cimo al sexto en ventas a pesar del giro en compras p\u00fablicas de medicamentos, afirma su Jorge Ancona, su director en M\u00e9xico.","og_url":"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/","og_site_name":"Prime Action Consulting","article_published_time":"2021-08-04T14:00:06+00:00","og_image":[{"url":"https:\/\/www.eleconomista.com.mx\/__export\/1561682579285\/sites\/eleconomista\/img\/2019\/06\/27\/bayer.jpg_1093282975.jpg","type":"","width":"","height":""}],"author":"primeactionmx","twitter_card":"summary_large_image","twitter_image":"https:\/\/www.eleconomista.com.mx\/__export\/1561682579285\/sites\/eleconomista\/img\/2019\/06\/27\/bayer.jpg_1093282975.jpg","twitter_misc":{"Escrito por":"primeactionmx","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/#article","isPartOf":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/"},"author":{"name":"primeactionmx","@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/person\/12b4e201995201db2de1bc5b99533471"},"headline":"Bayer Pharma crece a doble d\u00edgito y gana mercado en M\u00e9xico","datePublished":"2021-08-04T14:00:06+00:00","mainEntityOfPage":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/"},"wordCount":637,"publisher":{"@id":"https:\/\/backup.primeaction.com\/sp\/#organization"},"image":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/#primaryimage"},"thumbnailUrl":"https:\/\/www.eleconomista.com.mx\/__export\/1561682579285\/sites\/eleconomista\/img\/2019\/06\/27\/bayer.jpg_1093282975.jpg","articleSection":["Post Agronegocios"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/","url":"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/","name":"Bayer Pharma crece a doble d\u00edgito y gana mercado en M\u00e9xico · Prime Action Consulting","isPartOf":{"@id":"https:\/\/backup.primeaction.com\/sp\/#website"},"primaryImageOfPage":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/#primaryimage"},"image":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/#primaryimage"},"thumbnailUrl":"https:\/\/www.eleconomista.com.mx\/__export\/1561682579285\/sites\/eleconomista\/img\/2019\/06\/27\/bayer.jpg_1093282975.jpg","datePublished":"2021-08-04T14:00:06+00:00","breadcrumb":{"@id":"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/#primaryimage","url":"https:\/\/www.eleconomista.com.mx\/__export\/1561682579285\/sites\/eleconomista\/img\/2019\/06\/27\/bayer.jpg_1093282975.jpg","contentUrl":"https:\/\/www.eleconomista.com.mx\/__export\/1561682579285\/sites\/eleconomista\/img\/2019\/06\/27\/bayer.jpg_1093282975.jpg","caption":"Bayer Pharma crece a doble d\u00edgito y gana mercado en M\u00e9xico"},{"@type":"BreadcrumbList","@id":"https:\/\/backup.primeaction.com\/sp\/bayer-pharma-crece-a-doble-digito-y-gana-mercado-en-mexico\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/backup.primeaction.com\/sp\/"},{"@type":"ListItem","position":2,"name":"Bayer Pharma crece a doble d\u00edgito y gana mercado en M\u00e9xico"}]},{"@type":"WebSite","@id":"https:\/\/backup.primeaction.com\/sp\/#website","url":"https:\/\/backup.primeaction.com\/sp\/","name":"Prime Action Consulting","description":"Consultoria Especializada em Canais","publisher":{"@id":"https:\/\/backup.primeaction.com\/sp\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/backup.primeaction.com\/sp\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/backup.primeaction.com\/sp\/#organization","name":"Prime Action Consulting","url":"https:\/\/backup.primeaction.com\/sp\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/logo\/image\/","url":"https:\/\/backup.primeaction.com\/sp\/wp-content\/uploads\/sites\/8\/2019\/11\/logo-horiz-01-transp-2.png","contentUrl":"https:\/\/backup.primeaction.com\/sp\/wp-content\/uploads\/sites\/8\/2019\/11\/logo-horiz-01-transp-2.png","width":400,"height":185,"caption":"Prime Action Consulting"},"image":{"@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/backup.primeaction.com\/sp\/#\/schema\/person\/12b4e201995201db2de1bc5b99533471","name":"primeactionmx","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/19d334fbde47ddf970c0d3392d592bcaec217ee5e078358913a249e212d2899f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/19d334fbde47ddf970c0d3392d592bcaec217ee5e078358913a249e212d2899f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/19d334fbde47ddf970c0d3392d592bcaec217ee5e078358913a249e212d2899f?s=96&d=mm&r=g","caption":"primeactionmx"},"url":"https:\/\/backup.primeaction.com\/sp\/author\/primeactionmx\/"}]}},"_links":{"self":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts\/11389","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/comments?post=11389"}],"version-history":[{"count":1,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts\/11389\/revisions"}],"predecessor-version":[{"id":11391,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/posts\/11389\/revisions\/11391"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/media\/11392"}],"wp:attachment":[{"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/media?parent=11389"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/categories?post=11389"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/backup.primeaction.com\/sp\/wp-json\/wp\/v2\/tags?post=11389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}